ReviewFrontiers in immunology2021
Leveraging NKG2D Ligands in Immuno-Oncology.
Mercedes Beatriz Fuertes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
106 papers cite itlatest 60 shown
this papercites it
ReviewFrontiers in immunology2021
Mercedes Beatriz Fuertes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.